Overall, this may suggest a regulatory role of leptin, where increased levels, as observed during obesity, tip the balance toward an exacerbation of the immune system and a loss of immune self-tolerance, potentially worsening MS progression. This evidence concerns the gene LEP and myeloid sarcoma.